Our findings reveal that the genetic deletion of Mlkl or Ripk3 protects mice from age-related hepatic inflammation, steatosis, and fibrosis, hallmarks of MASLD. This evidence concerns the gene MLKL and metabolic dysfunction-associated steatotic liver disease.